Seattle Genetics
Biotechnology
Seattle Genetics is a biotechnology company headquartered in Bothell, Washington, on the outskirts of Seattle. Founded in 1998, the company is focused on developing and commercializing innovative therapies for the treatment of cancer. It is primarily known for Adcetris, an antibody drug conjugate (ADC) used for the treatment of Hodgkin lymphoma, systemic anaplastic large cell lymphoma, and other types of lymphoma. The company's pipeline also includes several other ADCs and antibody-based therapies, as well as small molecule drugs. Seattle Genetics has collaborations with a number of major pharmaceutical companies, including Takeda and Astellas, to develop and commercialize its products globally.
Top C-suite Members of Company
Connect with key decision-makers at Seattle Genetics. View contact details of C-suite executives and leadership team.
| Name | Title | Phone | Profile |
|---|
Email Formats
Discover the email patterns used at Seattle Genetics to connect with the right people.
Email Verification Tool
Get verified email addresses of any Seattle Genetics employee. Enjoy 100 free lookups every month.